HR Execs on the Move

Ophthotech

www.ophthotech.com

 
Ophthotech is a biopharmaceutical company specializing in the development of novel therapeutics to treat back of the eye diseases, with a focus on developing innovative therapies for age-related macular degeneration (AMD). Ophthotech`s most advanced product candidate, Fovista® anti-PDGF therapy, is in Phase 3 clinical trials for use in combination with anti-VEGF therapy that represents the current standard of care for the treatment of wet AMD. Ophthotech`s second product candidate, Zimura®, an inhibitor of complement factor C5, is being developed for the treatment of geographic atrophy, a form of dry AMD.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

NS Pharma

NS Pharma is a biopharmaceutical company focused on researching and developing treatments for rare diseases, with a current focus on optimizing exon skipping therapy for Duchenne muscular dystrophy.

Dassiet

We design and manufacture functional and sustainable applications for human and veterinary immobilization and mobility.

Kiel Laboratories

Kiel Laboratories, Inc. is a Gainesville, GA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Strategyx

Strategyx is a Somerville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CompleGen

CompleGen is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.